Tilt Investment Management Holdings’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$453K Sell
5,494
-1,547
-22% -$118K 0.49% 53
2023
Q3
$552K Hold
7,041
0.39% 77
2023
Q2
$625K Hold
7,041
0.41% 73
2023
Q1
$566K Buy
7,041
+900
+15% +$73.4K 0.42% 73
2022
Q4
$477K Buy
+6,141
New +$498K 0.4% 82

Other funds holding MDT

Tilt Investment Management Holdings's MDT Position: Q4 2023 in Review

Tilt Investment Management Holdings reduced its Medtronic (MDT) stake by 22% in Q4 2023, selling an estimated $118K and leaving 5,494 shares worth $453K. The position accounts for 0.49% of the portfolio, ranked #53.

Tilt Investment Management Holdings first reported a position in MDT in Q4 2022 and has held it in 5 quarters since. The position peaked at $625K in Q2 2023. 2,075 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • Tilt Investment Management Holdings held 5,494 shares of Medtronic worth $453K as of Q4 2023.
  • Tilt Investment Management Holdings sold 1,547 Medtronic shares in Q4 2023, an estimated $118K.
  • Medtronic made up 0.49% of Tilt Investment Management Holdings's portfolio in Q4 2023, its #53 holding.
  • Tilt Investment Management Holdings first reported a position in Medtronic in Q4 2022 and has held it in 5 quarters since.
  • Tilt Investment Management Holdings's Medtronic position peaked at $625K in Q2 2023.
  • 2,075 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q4 2023, filed 31 Jan 2024.